Skip to content
Clinical Trials – home
BelgiumBack to Belgium

Clinical trials in Maldegem – page 107

1 297 clinical trials in Maldegem, Belgium. Every trial is listed in the EU Clinical Trials Register and updated daily.

Maldegem at a glance
1 297
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

1 297 trials in Maldegem

Open in trial search

Study of Belrestotug and Dostarlimab for Patients with Untreated Advanced Non-Small Cell Lung Cancer

Registered drug
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Dostarlimab
  • Sponsor:Glaxosmithkline Research & Development Limited

Study Comparing Patritumab Deruxtecan and Platinum-based Chemotherapy for Patients with Advanced EGFR-mutated Non-small Cell Lung Cancer After EGFR Therapy Failure

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Daiichi Sankyo Inc.

HIV infection

Not recruiting

Study Comparing Two Drug Regimens for HIV: Lamivudine and Dolutegravir Sodium vs. Emtricitabine, Tenofovir Alafenamide, and Bictegravir in HIV-Positive Patients

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Bictegravir
  • Sponsor:Universitair Ziekenhuis Gent

Acute myeloid leukaemia+1

Not recruiting

Study on Midostaurin and Decitabine for Adults with Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome Who Are Unfit for Intensive Treatment

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Decitabine
  • Sponsor:Hemato-Oncologie voor Volwassenen Nederland (Hovon) Stichting

Study of Tarlatamab Treatment for Patients with Small Cell Lung Cancer Who Have Not Responded to Two or More Previous Treatments

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Siltuximab
  • Sponsor:Amgen Inc.

Transplant rejection

Not recruiting

Study on Efgartigimod for Patients with Antibody-Mediated Rejection after Kidney Transplant

Registered drug
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Efgartigimod Alfa
  • Sponsor:Argenx

Endometrial cancer+2

Not recruiting

Study on Selinexor as Maintenance Therapy for Patients with Advanced or Recurrent Endometrial Cancer After Chemotherapy

Registered drug
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Selinexor
  • Sponsor:Karyopharm Therapeutics Inc.

Renal cell carcinoma

Not recruiting

Study Comparing Tivozanib and Nivolumab Combination to Tivozanib Alone in Patients with Renal Cell Carcinoma After Previous Immune Therapy

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Nivolumab
  • Sponsor:Aveo Pharmaceuticals Inc.

Study on BGC101 for Treating Peripheral Arterial Disease with Critical Limb Ischemia in Patients Not Responding to Standard Treatments

Investigational
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Autologous Blood-Derived Endothelial Progenitor Cells, Haematopoietic Stem/Progenitor Cells, Activated Dendritic Cells And T Helper Cells
  • Sponsor:Biogencell Ltd.

Cystic fibrosis

Not recruiting

Long-term safety and efficacy study of elexacaftor/tezacaftor/ivacaftor treatment in people with cystic fibrosis who have non-F508del genetic mutations

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:0–17 years · 18–64 years
  • Substances:Elexacaftor
  • Sponsor:Vertex Pharmaceuticals Inc.

Study on Talazoparib and Enzalutamide for Patients with Metastatic Castration-Resistant Prostate Cancer

Registered drug
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Enzalutamide
  • Sponsor:Pfizer Inc.

Study Comparing ONC-392 and Docetaxel for Patients with Metastatic Non-Small Cell Lung Cancer After PD-1/PD-L1 Inhibitor Treatment

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Docetaxel
  • Sponsor:Oncoc4 Inc.

Other cities in Belgium

The busiest research cities in the country

All 164 cities in Belgium

Clinical research in Maldegem

What the registry says about research in the country

01 Dermatology Studies

Research focusing on plaque psoriasis and atopic dermatitis, evaluating novel therapeutic approaches for moderate to severe cases. Studies aim to assess the effectiveness of various treatment options for patients with persistent skin conditions.

  • Plaque Psoriasis Management
  • Atopic Dermatitis Treatment
  • Dose Optimization Studies

Investigations include comparative analyses between new treatments and established therapies.

02 Chronic Skin Conditions

Clinical research examining chronic spontaneous urticaria and neurodermatitis, with trials designed to evaluate innovative treatments for managing persistent symptoms and improving patient quality of life.

  • Urticaria Activity Reduction
  • Pruritus Management
  • Symptom Control Studies

Trials focus on addressing challenging symptoms in treatment-resistant cases.

03 Treatment Innovation

Advanced research into targeted therapies for various dermatological conditions, comparing new biological treatments with placebo to establish efficacy and safety profiles.

  • Biological Therapy Assessment
  • Novel Treatment Approaches
  • Long-term Safety Evaluation

Studies emphasize patient response to innovative therapeutic interventions.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.